Tracking myasthenia gravis with a smartphone app
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial is testing a new way to track your generalized myasthenia gravis (gMG) using a smartphone app and a wearable activity monitor. It’s not testing a drug – it’s about improving how doctors monitor your condition remotely, which might help you better manage your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed diagnosis of generalized myasthenia gravis (gMG), which means your doctor has verified it with tests like antibody tests or other specific checks.
- Your MGFA class must be from IIa to IVb — this is a scale doctors use to describe how severe your gMG is. If you’re not sure, ask your doctor.
- You must own a personal smartphone that is up to date enough: iPhone with iOS 16 or newer, or Android with version 8 or newer.
- You must be able to read the app in one of the available languages and understand the pictures it shows.
- You must be able to wear an activity monitor (like a fitness tracker) on your wrist or body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable sensors to track symptoms of myasthenia gravis in daily life. The goal is to see if these devices can better monitor how the disease changes over time.
This study uses small wearable sensors and a smartphone app (the BioDigit MG system) to track changes in muscle strength and daily activity over time in people starting VYVGART for generalized myasthenia gravis. It aims to see if this digital tool can accurately measure how well the treatment works.
This study tests whether remote monitoring through smartphone apps can effectively track myasthenia gravis symptoms and help manage care from home, instead of frequent in-person visits.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.
This study uses digital tools like questionnaires and smartphone tests to measure how myasthenia gravis affects you. It aims to create a better way for doctors to track your symptoms and adjust treatment.
Hear when a new Myasthenia Gravis, Generalized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.